Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer
Condition: Breast Cancer Intervention: Drug: nab-paclitaxel Sponsor: Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials